EVANS DAVID THOMAS (Chief Financial Officer) purchased 169.6% of their position (200K shares) of CARDLYTICS, INC. on the open market
Open‑market purchase worth $129.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/19/2026ACC: 0001628280-26-036474
Officer· Chief Financial Officer
Since Aug 2018
+200K
Net shares
Net buyer
$129.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
200K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
$0.65
Trade value
$97.35K
% of position
127.2%
5/15/2026
117.93K→267.93K
Common Stock
Direct
Shares
+50K
Price / share
$0.63
Trade value
$31.65K
% of position
18.7%
5/18/2026
267.93K→317.93K
Total
Net shares
+200K
Net value
$129K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/15/2026 | P · Purchase | +150K | $0.65 | $97.35K | 127.2% | 117.93K | 267.93K |
| Common Stock Direct | 5/18/2026 | P · Purchase | +50K | $0.63 | $31.65K | 18.7% | 267.93K | 317.93K |
| Total | +200K | $129K | ||||||
Derivative Transactions0
No derivative transactions reported